Home

Paul Peter Tak, CEO: Candel Therapeutics CADL Planned sale · Filed 09/10

Trade details

Type
Planned sale notice
Planned sale date
26/09/10
Filed
26/09/10

0.4% of shares outstanding to be sold

Candel Therapeutics trades, last 26 weeks

What else happened in Candel Therapeutics around then

Filed or reported within 30 days of the trade day · 08/11~10/10

Paul Peter Tak's recent trades

  • Paul Peter Tak

    Sell10b5-1 planCandel Therapeutics

    $226K

    Filed 25/03/20

  • Paul Peter Tak

    Sell10b5-1 planCandel Therapeutics

    $3,600

    Filed 25/03/20

  • Paul Peter Tak

    Planned sale10b5-1 planCandel Therapeutics

    $654.4K

    Filed 25/03/18

  • Paul Peter Tak

    SellCandel Therapeutics

    $156.9K

    Filed 25/01/17

  • Paul Peter Tak

    Planned saleCandel Therapeutics

    $156.6K

    Filed 25/01/15

Paul Peter Tak, CEO — plans to sell 280,245 sh of Candel Therapeutics CADL · $3.4M · around 09/10 · 10b5-1 plan | Whalegun